Total respiratory system compliance in asymptomatic infants with cystic fibrosis

Robert Tepper, P. W. Hiatt, H. Eigen, J. Smith

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Total respiratory system compliance (Crs) was assessed by the weighted spirometer method in 11 asymptomatic infants (mean age, 11.1 months) with cystic fibrosis (CF) who had normal chest radiographs. In addition to Crs, functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were measured. There was no significant difference in FRC between normal controls (n=36) and CF infants (190 ± 69 versus 186 ± 63 ml; p<0.08), although the CF group had a higher RR (32 ± 7 versus 37 ± 7 BPM; p<0.05) and a lower MI (45 ± 7 versus 40 ± 8%; p<0.05), reflecting an abnormal distribution of ventilation. The lower Crs (9.0 ± 3.4 versus 5.7 ± 2.8 ml/cm H2O; p<0.01) and the lower specific compliance, Crs/FRC (0.049 ± 0.013 versus 0.029 ± 0.007 1/cm H2O; p<0.0001), in the CF group were the parameters that best distinguished the normal control and CF infants. We conclude that the measurement of Crs represents a noninvasive method for detecting early pulmonary function abnormalities in CF infants.

Original languageEnglish
Pages (from-to)1075-1079
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume135
Issue number5
StatePublished - 1987

Fingerprint

Cystic Fibrosis
Respiratory System
Compliance
Functional Residual Capacity
Respiratory Rate
Ventilation
Thorax
Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Total respiratory system compliance in asymptomatic infants with cystic fibrosis. / Tepper, Robert; Hiatt, P. W.; Eigen, H.; Smith, J.

In: American Review of Respiratory Disease, Vol. 135, No. 5, 1987, p. 1075-1079.

Research output: Contribution to journalArticle

Tepper, Robert ; Hiatt, P. W. ; Eigen, H. ; Smith, J. / Total respiratory system compliance in asymptomatic infants with cystic fibrosis. In: American Review of Respiratory Disease. 1987 ; Vol. 135, No. 5. pp. 1075-1079.
@article{e011a7d2a14f4a388fb8fc4d4b5128ea,
title = "Total respiratory system compliance in asymptomatic infants with cystic fibrosis",
abstract = "Total respiratory system compliance (Crs) was assessed by the weighted spirometer method in 11 asymptomatic infants (mean age, 11.1 months) with cystic fibrosis (CF) who had normal chest radiographs. In addition to Crs, functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were measured. There was no significant difference in FRC between normal controls (n=36) and CF infants (190 ± 69 versus 186 ± 63 ml; p<0.08), although the CF group had a higher RR (32 ± 7 versus 37 ± 7 BPM; p<0.05) and a lower MI (45 ± 7 versus 40 ± 8{\%}; p<0.05), reflecting an abnormal distribution of ventilation. The lower Crs (9.0 ± 3.4 versus 5.7 ± 2.8 ml/cm H2O; p<0.01) and the lower specific compliance, Crs/FRC (0.049 ± 0.013 versus 0.029 ± 0.007 1/cm H2O; p<0.0001), in the CF group were the parameters that best distinguished the normal control and CF infants. We conclude that the measurement of Crs represents a noninvasive method for detecting early pulmonary function abnormalities in CF infants.",
author = "Robert Tepper and Hiatt, {P. W.} and H. Eigen and J. Smith",
year = "1987",
language = "English",
volume = "135",
pages = "1075--1079",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Total respiratory system compliance in asymptomatic infants with cystic fibrosis

AU - Tepper, Robert

AU - Hiatt, P. W.

AU - Eigen, H.

AU - Smith, J.

PY - 1987

Y1 - 1987

N2 - Total respiratory system compliance (Crs) was assessed by the weighted spirometer method in 11 asymptomatic infants (mean age, 11.1 months) with cystic fibrosis (CF) who had normal chest radiographs. In addition to Crs, functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were measured. There was no significant difference in FRC between normal controls (n=36) and CF infants (190 ± 69 versus 186 ± 63 ml; p<0.08), although the CF group had a higher RR (32 ± 7 versus 37 ± 7 BPM; p<0.05) and a lower MI (45 ± 7 versus 40 ± 8%; p<0.05), reflecting an abnormal distribution of ventilation. The lower Crs (9.0 ± 3.4 versus 5.7 ± 2.8 ml/cm H2O; p<0.01) and the lower specific compliance, Crs/FRC (0.049 ± 0.013 versus 0.029 ± 0.007 1/cm H2O; p<0.0001), in the CF group were the parameters that best distinguished the normal control and CF infants. We conclude that the measurement of Crs represents a noninvasive method for detecting early pulmonary function abnormalities in CF infants.

AB - Total respiratory system compliance (Crs) was assessed by the weighted spirometer method in 11 asymptomatic infants (mean age, 11.1 months) with cystic fibrosis (CF) who had normal chest radiographs. In addition to Crs, functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were measured. There was no significant difference in FRC between normal controls (n=36) and CF infants (190 ± 69 versus 186 ± 63 ml; p<0.08), although the CF group had a higher RR (32 ± 7 versus 37 ± 7 BPM; p<0.05) and a lower MI (45 ± 7 versus 40 ± 8%; p<0.05), reflecting an abnormal distribution of ventilation. The lower Crs (9.0 ± 3.4 versus 5.7 ± 2.8 ml/cm H2O; p<0.01) and the lower specific compliance, Crs/FRC (0.049 ± 0.013 versus 0.029 ± 0.007 1/cm H2O; p<0.0001), in the CF group were the parameters that best distinguished the normal control and CF infants. We conclude that the measurement of Crs represents a noninvasive method for detecting early pulmonary function abnormalities in CF infants.

UR - http://www.scopus.com/inward/record.url?scp=0023631210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023631210&partnerID=8YFLogxK

M3 - Article

C2 - 3579006

AN - SCOPUS:0023631210

VL - 135

SP - 1075

EP - 1079

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 5

ER -